— Know what they know.
Not Investment Advice

SYNH NASDAQ

Syneos Health, Inc.
1W: +0.6% 1M: +0.7% 3M: +2.0% 1Y: -10.2% 3Y: -19.5% 5Y: -13.8%
$42.98
Last traded 2023-09-29 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $4.5B mcap · 103M float · 1.28% daily turnover

Cash Flow Trends

Operating Cash Flow
$427M -5.2% ▼
5Y CAGR: +16.6%
Capital Expenditures
$93M -64.4% ▼
5Y CAGR: +16.3%
Free Cash Flow
$334M -15.2% ▼
5Y CAGR: +16.7%
Dividends Paid
$0 +0.0% ▲
Buybacks
$150M -27.6% ▼
Net Change in Cash
$6M +103.3% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income$24M$131M$193M$235M$266M
Depreciation & Amort.$274M$242M$222M$236M$247M
Stock-Based Comp.$34M$55M$58M$65M$57M
Change in Working Capital-$4M-$93M-$42M-$137M-$127M
Other Non-Cash Items-$25M$23M-$3M$5M-$15M
Operating Cash Flow$303M$318M$425M$450M$427M
— Investing Activities —
Capital Expenditures-$55M-$64M-$50M-$57M-$93M
Acquisitions (Net)-$91M-$18M-$454M-$285M-$12M
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0-$17M$2M$1M-$8M
Investing Cash Flow-$145M-$82M-$504M-$340M-$106M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased-$75M-$57M-$70M-$118M-$150M
Dividends Paid$0$0$0$0$0
Other Financing-$319M-$215M$178M-$278M-$339M
Financing Cash Flow-$319M-$215M$178M-$278M-$339M
Net Change in Cash-$166M$8M$108M-$166M$6M
Cash End of Period$156M$164M$272M$106M$112M
Free Cash Flow$249M$255M$375M$393M$334M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms